跳至主要内容
临床试验/EUCTR2004-001673-25-IT
EUCTR2004-001673-25-IT进行中(未招募)1 期

EFFECTS OF ANGIOTENSIN RECEPTOR ANTAGONIST ON CHRONIC NEPHROPATY IN KIDNEY TRANSPLANTED PATIENTS. A PILOT STUDY.

OSPEDALE S. RAFFAELE0 个研究点开始时间: 2005年6月22日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

发起方
OSPEDALE S. RAFFAELE

相似试验

进行中(未招募)
1 期
Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke. - Telmisartan in Acute Stroke
EUCTR2006-005082-19-GBResearch Innovation Services, University of Nottingham34
进行中(未招募)
不适用
Effects of an ARB on Microcirculation in Essential HypertensioEssential hypertensionMedDRA version: 14.1Level: LLTClassification code 10004254Term: Benign essential hypertensionSystem Organ Class: 10047065 - Vascular disorders
EUCTR2008-005432-32-GBSt. George's University of London (SGUL)46
进行中(未招募)
1 期
Importance of ARB medication in preventing valvular heart disease
EUCTR2018-004653-24-DKOdense Universitets Hospital280
招募中
不适用
Effect of angiotension 1 receptor antagonist on acute lung injuryacute lung injury
JPRN-UMIN000003801Tokyo Medical and Dental University200
进行中(未招募)
不适用
Establishing the benefits of a tablet commonly used to treat raised blood pressure in people with Chronic Kidney Disease stage 3b.We plan a large pragmatic trial to test the potential for spironolactone to to reduce overall cardiovascular events and death, to delay the decline in renal function, and to improve surrogate markers for vascular disease in people with stage 3b (eGFR 30-44 ml/min/1.73m2)Chronic Kidney Disease.MedDRA version: 15.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseSystem Organ Class: 100000004857MedDRA version: 15.1Level: PTClassification code 10018355Term: Glomerular filtration rateSystem Organ Class: 10022891 - InvestigationsMedDRA version: 15.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849
EUCTR2012-002672-13-GBniversity of Oxford, Clinical Trials and Research Governance Office2,616